Koru Medical Systems (Nasdaq:KRMD) announced today that it submitted its Freedom60 infusion system for FDA 510(k) clearance. The submission covers the use of the Freedom60 infusion system with the Hizentra 50 mL prefilled syringe. In January, Mahwah, New Jersey-based Koru inked a development agreement with a manufacturer of subcutaneous immunoglobulin therapy (SCIg). The deal sought […]
Koru Medical Systems
Koru Medical appoints new VP of medical affairs
Koru Medical Systems (Nasdaq:KRMD) announced today that it appointed Brent Rutland as its new VP of medical affairs. Rutland joins the Mahwah, New Jersey-based drug delivery technology developer with 27 years of experience in the space. Most recently, he served as a senior director for health outcomes at La Jolla Pharmaceutical Company. Get the full […]
Koru Medical names former Fresenius Kabi VP as chief technology officer
Koru Medical Systems (Nasdaq:KRMD) announced that it appointed medtech veteran Brian Case as its new chief technology officer. With more than 20 years of experience in medtech R&D, Case joins after spending more than 16 years at Fresenius Kabi as VP of R&D. Before Fresenius Kabi, he served as an R&D program manager for advanced […]
Koru Medical Systems rises as Q4 earnings beat Street projections
Koru Medical Systems (NSDQ:KRMD) shares ticked up today on fourth-quarter results that topped the consensus forecast. The Chester, New York-based infusion technology developer posted losses of $1.1 million, or 2¢ per share, on sales of $6.5 million for the three months ended Dec. 31, 2021, for a bottom-line slide further into the red on sales […]
Koru Medical names Linda Tharby as CEO
Koru Medical Systems (NSDQ:KRMD) today announced that it has appointed Linda Tharby as president and CEO, effective April 12. Tharby will succeed interim CEO Jim Beck, who will continue to serve on the company’s board of directors. “On behalf of the board of directors and our entire company, I’d like to thank Jim for stepping up […]
Koru Medical slides on missed earnings forecast
Koru Medical Systems (NSDQ:KRMD) shares dipped today on second-quarter results that missed the consensus earnings forecast. The Chester, N.Y.-based infusion system developer posted losses of -$1.1 million, or -3¢ per share, on sales of $7.7 million for the three months ended June 30, 2020, for a bottom-line slide into the red despite sales growth of […]
RMS Medical rebrands as Koru Medical Systems
Infusion system-maker RMS Medical (NDSQ:REPR) said today that it is rebranding as Koru Medical Systems, effective tomorrow. The newly branded Koru Medical Systems said it will commence trading its common stock under the new ticker symbol “KRMD” on the NASDAQ market tomorrow as well. The company’s email address domain will change to @korumedical.com and its […]